While a number of studies have evaluated the expression of SST and D2 receptors among prolactinomas, our study is unique in that it evaluated the expression of SST2, SST5 and D2R within a single cohort. The gene discussed is SSTR5; the disease is prolactin-producing pituitary gland adenoma.